Authorised representative profileBoston Scientific Hong Kong Limited
Hong Kong MDACS262 represented devices23 applicantsDec 16, 2005 – Oct 15, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
262
Total devices
23
Applicants
2005
First representation
2024
Most recent
AR overview
- Authorised representative (EN)
- Boston Scientific Hong Kong Limited
- Phone
- 29607100
Timeline
- First representation
- Dec 16, 2005
- Most recent
- Oct 15, 2024
Regulatory footprint
Search Boston Scientific Hong Kong Limited across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk class distribution
II86
III51
IV125
Applicant partnerships
Top manufacturers represented by this AR
Boston Scientific Corporation
209 devices
Cardiac Pacemakers, Incorporated, a wholly owned subsidiary of Guidant Corporation, a wholly owned subsidiary of Boston Scientific Corporation
13 devices
Lake Region Medical
8 devices
Cardiac Pacemakers, Incorporated, a wholly owned subsidiary of Guidant Corporation a wholly owned subsidiary Boston Scientific Corporation
4 devices
Farapulse, Inc.
3 devices
Cardiac Pacemakers Incorporated, a wholly owned subsidiary of Guidant Corporation, a wholly owned subsidiary of Boston Scientific Corporation
3 devices
Cardiac Pacemakers, Incorporated, a wholly owned subsidiary of Guidant Corporation a wholly owned subsidiary of Boston Scientific Corporation
3 devices
Cardiac Pacemakers, Incorporated: a wholly owned subsidiary of Guidant Corporation, a wholly owned subsidiary of Boston Scientific Corporation
2 devices
Hemoteq AG
2 devices
Boston Scientific Corporation - Cardiac Pacemakers, Incorporated
2 devices
Recent registrations
Latest 15 MDACS listings represented by Boston Scientific Hong Kong Limited
Catheters, Vascular, Guiding
导管,血管,引导
Oct 15, 2024
- Risk class
- IV
- Applicant
- Boston Scientific CorporationBoston Scientific
Dilators, Ureteral, Access Sheath
扩张器、输尿管、通路鞘
Oct 15, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Forceps, Biopsy, Flexible Endoscopic
镊子、活检、软式内窥镜
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Retrieval Baskets, Urological Stone
取回篮,泌尿科结石
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Aspirator/Irrigators, Endoscopy
吸引器/冲洗器, 内窥镜检查
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Guide Wires
导丝
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Catheters, Urinary, Ureteral
导管、小便池、输尿管
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Catheters, Vascular, Angioplasty, Balloon
导管、血管、血管成形术、球囊
Oct 07, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Gastric Balloons, Appetite-Suppressing
胃气球,抑制食欲
Sep 20, 2024
- Risk class
- III
- Applicant
- Apollo Endosurgery, Inc.Apollo Endosurgery, Inc.
Probes, Cryoablation
探针, 冷冻消融
Aug 29, 2024
- Risk class
- III
- Applicant
- Boston Scientific CorporationBoston Scientific
Stents, Gastroduodenal
胃十二指肠支架
Aug 29, 2024
- Risk class
- III
- Applicant
- Boston Scientific CorporationBoston Scientific
Defibrillator/Cardioverter/Pacemakers, Implantable, Resynchronization
除颤器/心脏复律器/起搏器,植入式,再同步
Jul 26, 2024
- Risk class
- IV
- Applicant
- Cardiac Pacemakers, Incorporated, a wholly owned subsidiary of Guidant Corporation, a wholly owned subsidiary of Boston Scientific CorporationBoston Scientific
Electrodes, Cardiac
电极,心脏
Jul 24, 2024
- Risk class
- IV
- Applicant
- Boston Scientific CorporationBoston Scientific
Aspirator/Irrigators, Endoscopy
吸引器/冲洗器, 内窥镜检查
Jul 24, 2024
- Risk class
- II
- Applicant
- Boston Scientific CorporationBoston Scientific
Guide Wires
导丝
Jul 24, 2024
- Risk class
- IV
- Applicant
- Lake Region MedicalInteger Holdings Corp.
About this profile
Boston Scientific Hong Kong Limited serves as the authorised representative for 262 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.